1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

unipath?

Discussion in 'American Pathology Partners' started by Anonymous, Nov 22, 2010 at 10:12 PM.

  1. Anonymous

    Anonymous Guest

    Coming from pharma ..how is laboratory sales step forward or backward? Money wise? Anything helps!
     
  2. Anonymous

    Anonymous Guest

    It depends on what are you are looking at, what state?
     
  3. Anonymous

    Anonymous Guest

    Pharma reps do not make any money at all. Bottom feeders of the medical industry. They work from 10-2 three days a week. Come on now.
     
  4. Anonymous

    Anonymous Guest

    Well...still curious...is Lab sales a step foward or back? Whats the deal with this company?
    bounus/goals obtainable? Not looking for a "Cake Walk", just looking for real responses!!

    Thanks
     
  5. Anonymous

    Anonymous Guest

    Lab sales are a big step forward from pharma. Good base and open ended commission structure i.e. the more you sell/grow the more you make
     
  6. Anonymous

    Anonymous Guest

    Lab sales is the way to go....for people that love to sell, work, and achieve and exceed goals. And those that enjoy being rewarded for their work.
     
  7. Anonymous

    Anonymous Guest

    Is Unipath a well known lab company? how are their products?
     
  8. Anonymous

    Anonymous Guest

    Whats working for this company like? whats reputation in industry? quota's obtainable?
     
  9. Anonymous

    Anonymous Guest

    Quotas are obtainable and commission plan is op ended.
     
  10. Anonymous

    Anonymous Guest

    Whose thier Competition? Are the Turn and Burn type company? How long is Training?
     
  11. Anonymous

    Anonymous Guest

    Competition includes CBL, Bostwick, Caris, DGX and LCA
     
  12. Anonymous

    Anonymous Guest

    this company cant compete with Caris, or Labcorp or sonic. dont fool yourself.
     
  13. Anonymous

    Anonymous Guest

    The lab business is quit a bit different than pharma and if you don’t have decent market share when taking over a territory it will be a long uphill ride. You need to ask how much business is coming into the territory now. Anything less than $100,000 in revenue a month is not going to be good enough.
     
  14. Anonymous

    Anonymous Guest

    Company is a mess.
     
  15. Anonymous

    Anonymous Guest

    Why is this company a mess? What makes you say that?
     
  16. Anonymous

    Anonymous Guest

    I think thsat msg. was from some crack head
     
  17. Anonymous

    Anonymous Guest

    WELL IN PHARMA YOU DID NOT DO JACK SHIT! SORRY BUT TRUE, WHAT LUNCHES AND DROP OFF SAMPLES?? GET READY TO WORK YOUR ASS OFF AND STILL NOT MAKE A DIME IN COMMISSION, GOOD LUCK OUT THERE!